Concord Biotech Ltd. News and Updates

Keep track of all breaking news on Concord Biotech Ltd. from all sources in a single place.

09 Apr 2025

1733.10

4.79%

Here's why Concord Biotech shares gained 5% in trade on April 9; details

Business Standard

The uptick in Concord Biotech share price came after the company was granted final approval from the USFDA for marketing its Teriflunomide Tablets, 7 mg and 14 mg

Concord Biotech Ltd.'s price crossed above 30Day SMA today

Concord Biotech Ltd.

14 Feb 2025, 12:13PM

1733.10

4.79%

Concord Biotech shares plunge 16% on reporting Q3 results; PAT down 2% YoY

Business Standard

In Q3, Concord Biotech reported a 2 per cent decline in consolidated net profit to Rs 75.9 crore as compared to Rs 77.6 crore a year ago

Number of FII/FPI investors increased from 110 to 126 in Dec 2024 qtr.

Concord Biotech Ltd.

22 Jan 2025

1733.10

4.79%

Concord Biotech: Citi Reinitiates Coverage With 'Neutral' Amid API Growth Slowdown

NDTV Profit

The API segment sales have experienced a decline of around 9% in financial year 2024 and 3% in first half of financial year 2025E.

Concord Biotech Ltd. is trading above its 30 day SMA of 1656.6

Concord Biotech Ltd.

12 Nov 2024

1733.10

4.79%

Concord Biotech Results Earnings Call for Q2FY25

Conference Call with Concord Biotech Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.

Concord Biotech Ltd.

05 Sep 2024

1733.10

4.79%

Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'

Business Standard

Antique Broking is bullish on Concord's business model, new launches and niche products

Concord Biotech Ltd. is trading below its 50 day SMA of 1788.2

Concord Biotech Ltd.

28 May 2024

1733.10

4.79%

Concord Biotech Shareholder Pares Stake For Rs 482 Crore

NDTV Profit

Ontario Inc. owned 5.39% in the Jhunjhunwala family-backed company as of March 2024.

Concord Biotech Ltd. has lost -25.53% in the last 3 Months

Concord Biotech Shares Lowest In Two Months After Large Trade

NDTV Profit | 28 May 2024

Concord Biotech Ltd.

02 Jan 2024

1733.10

4.79%

Choice Broking initiates coverage on Concord Biotech with Outperform' rating; sees 16% upside

livemint

Concord Biotech has over the years built a portfolio of 23 fermentation APIs, scaled manufacturing capabilities and backwardly integrated its API to KSM creating a competitive edge in the industry.

Concord Biotech Ltd. is trading below its 50 day SMA of 1788.2

Concord Biotech Ltd.

06 Nov 2023

1733.10

4.79%

Concord Biotech Share Price Live blog for 06 Nov 2023

livemint

Concord Biotech stock price went up today, 06 Nov 2023, by 1.23 %. The stock closed at 1130.05 per share. The stock is currently trading at 1143.95 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.

Concord Biotech Ltd. has lost -25.53% in the last 3 Months

Concord Biotech Ltd.

27 Oct 2023

1733.10

4.79%

Concord Biotech Share Price Live blog for 27 Oct 2023

livemint

Concord Biotech stock price went down today, 27 Oct 2023, by -2.37 %. The stock closed at 1194.2 per share. The stock is currently trading at 1165.85 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.

Concord Biotech Ltd.'s price crossed above 30Day SMA today

Concord Biotech Ltd.

26 Oct 2023

1733.10

4.79%

Concord Biotech Share Price Live blog for 26 Oct 2023

livemint

Concord Biotech stock price went up today, 26 Oct 2023, by 3.12 %. The stock closed at 1158.05 per share. The stock is currently trading at 1194.2 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.

Concord Biotech Ltd. is trading below its 50 day SMA of 1788.2

34.94% Fall from 52W High

Concord Biotech Ltd. News and Updates

Keep track of all breaking news on Concord Biotech Ltd. from all sources in a single place.